Dark

BNTC
Benitec Biopharma Inc. Common Stock
stock NASDAQ

At Close

Oct 2, 2026 3:59:56 PM EDT

8.97USD-6.367%(-0.61)135,139

0.00Bid 0.00Ask 0.00Spread

Pre-market

0.00USD-100.000%(-9.58)0

After-hours

0.00USD0.000%(0.00)0

OverviewOptionsHistoricalExchangesShortsNews

Dec 10, 2021

05:19AM EST Benitec Biopharma 10%+ Owner Steven Michael Oliveira Reported Purchase of 331,877 Shares @ Avg Price of $4.51/Share in Form 4 Filing on Thursday Benzinga

Nov 15, 2021

11:07AM EST Benitec Biopharma Q1 EPS $(0.62) Up From $(2.45) YoY Benzinga

08:14AM EST Benitec Biopharma Q1 Loss/shr $0.62 Vs. Loss/shr $2.45 Prior Year RTTNews

08:02AM EST Benitec Biopharma Discloses Q1 2022 Financial Results PR Newswire

Sep 22, 2021

01:04PM EDT Benitec Biopharma Receives Notice Of Allowance For U.S. Patent Titled 'REAGENTS FOR TREATMENT OF OCULOPHARYNGEAL MUSCULAR DYSTROPHY (OPMD) AND USE THEREOF' Benzinga

Sep 20, 2021

09:18AM EDT The Benitec Biopharma Inc. (BNTC), a pharmaceutical company engaged in the development of gene-silencing therapies, on Monday posted an increased loss for the fiscal year 2021, amidst a decline in revenue and rise in operating expenses. RTTNews

08:11AM EDT Benitec Biopharma FY21 Sales $59K Benzinga

08:09AM EDT Benitec Biopharma FY Loss Attributable To Shareholders $13.9 Mln Or $3.23/shr Vs Loss Of $8.3 Mln Or $8.10/Shr Last Year RTTNews

08:02AM EDT Benitec Biopharma Provides Operational Update and Releases its 2021 Fiscal PR Newswire

Sep 13, 2021

03:59PM EDT Benitec Biopharma to present at H.C. Wainwright's 23rd Annual Global Investment PR Newswire

Sep 8, 2021

08:18AM EDT Benitec Biopharma Provides Positive Updates On BB-301 Pilot Dosing Study In Large Animals RTTNews

08:17AM EDT Benitec Biopharma Provides Positive Updates For BB-301 Development Program; BB-301 Phase 1b/2a Trial To Begin In 2022 RTTNews

08:17AM EDT Benitec Biopharma Provides Regulatory Updates for the BB-301 Development Program; BB-301 Phase 1b/2a Clinical Trial to Begin in 2022 Benzinga

08:10AM EDT Benitec Biopharma Provides Overview of the BB-301 Phase 1b/2a Clinical Trial PR Newswire

08:05AM EDT Benitec Biopharma Provides Positive Updates on the BB-301 Pilot Dosing Study in PR Newswire

08:03AM EDT Development Program; BB-301 Phase 1b/2a Clinical Trial to Begin in 2022 PR Newswire

08:02AM EDT Benitec Biopharma Provides Positive Regulatory Updates for the BB-301 Development Program; BB-301 Phase 1b/2a Clinical Trial to Begin in 2022 Benzinga

Jun 17, 2021

10:24AM EDT Benitec Biopharma Files For U.S. Patent Application Titled 'REAGENTS FOR TREATMENT OF HEPATITIS B VIRUS INFECTION' Benzinga

May 7, 2021

02:42PM EDT Pfizer Internal Target Is For 3B Doses Of COVID-19 Vaccine In 2021 Benzinga

Apr 28, 2021

02:37PM EDT Mid-Afternoon Market Update: Dow Drops 90 Points; Fed Leaves Rates Unchanged Benzinga

12:20PM EDT Mid-Day Market Update: Crude Oil Rises 2%; Protalix BioTherapeutics Shares Plunge Benzinga

10:25AM EDT Mid-Morning Market Update: Markets Mixed; Alphabet Tops Q1 Expectations Benzinga

07:26AM EDT The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping Benzinga

05:34AM EDT Benitec Biopharma Increased Previously Announced Bought Deal Offering of Common Stock to 3.03M Shares Priced @$4.25/Share Benzinga

Apr 27, 2021

10:31PM EDT Benitec Biopharma Increases Bought Deal Offering Of Common Stock To $12.9 Mln RTTNews

09:56PM EDT Benitec Biopharma Increases Previously Announced Bought Deal Offering of Common PR Newswire

04:45PM EDT Benitec Biopharma Announces $7.5 Million Bought Deal Offering of Common Stock PR Newswire

04:45PM EDT Benitec Biopharma Announces $7.5M Bought Deal Offering Of Common Stock Benzinga

Apr 13, 2021

09:28AM EDT Belgium To Continue With J&J Vaccine, Says Is Watching Situation Closely Benzinga

Mar 24, 2021

10:17AM EDT Mid-Morning Market Update: Markets Mostly Higher; General Mills Reports Downbeat Q3 Earnings Benzinga

Mar 23, 2021

02:41PM EDT Mid-Afternoon Market Update: Dow Falls Over 100 Points; Pacific Mercantile Bancorp Shares Surge Benzinga

12:05PM EDT Mid-Day Market Update: Crude Oil Down 4.5%; Hoth Therapeutics Shares Spike Higher Benzinga

10:19AM EDT Mid-Morning Market Update: Markets Edge Higher; IHS Markit Profit Beats Views Benzinga

Mar 22, 2021

04:40PM EDT Benitec Biopharma 13G Filing From Morgan Stanley Shows Raised Stake From ~13.1K Shares To ~249K Shares, Or 5.2% Stake In Co. Benzinga

Feb 24, 2021

09:26AM EST Benitec Biopharma's Gene Therapy For Rare Muscle Disorder Shows Encouraging Action In Animal Studies Benzinga

08:32AM EST Benitec Biopharma Announces Successful Results From Interim Analysis Of BB-301 Pilot Dosing Study RTTNews

08:30AM EST Benitec Biopharma Announces Results From Interim Analysis Of BB-301 Pilot Dosing Study Benzinga

08:30AM EST Benitec Biopharma Announces Successful Results from the Interim Analysis of the PR Newswire

Dec 7, 2020

02:34PM EST Benitec Biopharma Announces 2020 Annual Stockholder Meeting PR Newswire

Nov 20, 2020

08:06AM EST The Daily Biotech Pulse: Amarin Surges On Vascepa Data, Mesoblast Rallies On Novartis Deal, Decision Day For Eiger Benzinga

Nov 4, 2020

08:21AM EST The Daily Biotech Pulse: Alzheimer's Conference Underway, Biogen's Aducanumab Briefing Doc, Supernus Earnings Benzinga

Nov 3, 2020

07:38AM EST The Daily Biotech Pulse: Aurinia Pulls The Plug On Dry Eye Disease Study, Karyopharm's Positive Readout, Emergency Use Authorization For OraSure Benzinga

Oct 29, 2020

07:30AM EDT The Daily Biotech Pulse: Novartis Acquires Gene Therapy Company, Moderna's Japanese Vaccine Supply Deal Benzinga

Oct 6, 2020

04:05PM EDT Benitec Biopharma Announces Closing of $11.5 Million Public Offering and Full PR Newswire

Oct 5, 2020

09:12AM EDT Ladenburg Thalmann Downgrades Benitec Biopharma to Neutral Benzinga

Oct 2, 2020

03:22PM EDT Mid-Afternoon Market Update: Dow Falls 50 Points; IDT Shares Climb After Q4 Results Benzinga

03:04PM EDT Mid-Morning Market Update: Markets Open Lower; US Unemployment Rate Falls To 7.9% In September Benzinga

03:03PM EDT Mid-Day Market Update: Nasdaq Down 2%; American Renal Associates Shares Jump Benzinga

10:40AM EDT Mid-Morning Market Update: Markets Open Lower; US Unemployment Rate Falls To 7.9% In September Benzinga

09:07AM EDT Benitec Biopharma Prices Public Offering Of 3.23 Mln Shares At $3.10/Shr RTTNews

09:05AM EDT Benitec Biopharma Announces Pricing of $10.0 Million Public Offering PR Newswire

09:05AM EDT Benitec Biopharma Prices ~3.23M Shares At $3.10/Share Benzinga

Sep 23, 2020

04:58PM EDT Benitec Biopharma Q3 EPS $(8.10), Sales $102.00K Benzinga

04:55PM EDT Benitec Biopharma Provides Operational Update and Releases its 2020 Fiscal PR Newswire

Sep 1, 2020

08:15AM EDT Benitec Biopharma to present at H.C. Wainwright's 22nd Annual Global Investment PR Newswire